An Economic Evaluation of Voriconazole versus Amphotericin B for the Treatment of Invasive Aspergillosis in Canada
BACKGROUND: Invasive aspergillosis (IA) is a serious fungal infection that affects immunocompromised patients. The Global Comparative Aspergillosis study demonstrated that voriconazole, a new broad-spectrum triazole, had better responses and improved survival compared with conventional amphotericin...
Saved in:
Main Authors: | Coleman Rotstein, Michel Laverdière, Anne Marciniak, Farzad Ali |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2004-01-01
|
Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
Online Access: | http://dx.doi.org/10.1155/2004/183087 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Economic Evaluation of Voriconazole for the Treatment of Candidemia in Canadian Adults
by: Coleman Rotstein, et al.
Published: (2008-01-01) -
Refractory Scedosporium apiospermum Keratitis Successfully Treated with Combination of Amphotericin B and Voriconazole
by: Mohd-Tahir Fadzillah, et al.
Published: (2013-01-01) -
Real-World Effectiveness and Safety of Isavuconazole Versus Amphotericin B for Patients with Invasive Mucormycosis
by: Jiayuan Qin, et al.
Published: (2025-01-01) -
Safety and recommendation of voriconazole for invasive pulmonary aspergillosis in severe liver disease patients: a retrospective cohort study
by: Xin Zhang, et al.
Published: (2025-01-01) -
Efficacy and safety of echinocandins versus triazoles or amphotericin B in the treatment of invasive fungal infections in paediatric patients: a systematic review
by: Lu Lu Htet, et al.
Published: (2025-01-01)